banner
JAK inhibitor Decernotinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ373

JAK inhibitor Decernotinib, Purity ≥98%

Synonym: Decernotinib; 944842-54-0; Adelatinib; VX-509; Decernotinib(VX-509); VRT-831509; Decernotinib (VX-509); JAK inhibitor

  • CAS Number: 944842-54-0
  • Compound CID: 59422203
img
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Decernotinib, soluble in DMSO and warmed ethanol and insoluble in water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK1, JAK2, JAK3, and TYK2.
Molecular Weight
392.38
Molecular Formula
C18H19F3N6O
Targets
JAK1: 11 nM; JAK1: 11 nM (Ki); JAK2: 13 nM (Ki); JAK3: 2.5 nM (Ki); TYK2: 13 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 70 mg/mL (178.39 mM); Water: Insoluble; Warmed ethanol: 18 mg/mL (45.87 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Decernotinib is used to explore its selectivity for inhibiting JAK3 and its potential benefits in treating rheumatoid arthritis.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0